Recently, miR‐181b has been found to contribute to tumour growth and metastasis by suppressing the anti‐tumour gene TIMP3 and induced EMT process in multiple cancers, including hepatocellular carcinoma and breast cancer.29, 31, 40. Here, TIMP3 is linked to breast cancer.